Skip to content
Active, not recruitingPhase 3

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

NCT06809595 · Definium Therapeutics US, Inc.

Closed to entry
Status
Not accepting participants
Phase 3
Phase
245
Target enrolment
36
Study sites
10 US states

What it is testing

Summary

A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Generalized Anxiety Disorder - Panorama

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Change from Baseline in Hamilton Anxiety Rating Scale (HAM-A) total score at Week 12

    Measured over Baseline to Week 12

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 74 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: 1. Diagnosis of GAD per DSM-5 2. Male or female aged 18 to 74 3. HAM-A Total Score ≥20 Exclusion Criteria: 1. Certain psychiatric disorders (other than generalized anxiety disorder) 2. First degree relative with or lifetime history of a psychotic disorder or bipolar disorder 3. Current diagnosis of alcohol or substance use disorder (excluding nicotine and caffeine) 4. Any clinically significant unstable illness

Where

36 study sites

FacilityCityRegionCountry
Preferred Research Partners, Inc.Little RockArkansasUnited States
Psychedelic Science InstituteLos AngelesCaliforniaUnited States
West Los Angeles VA Medical CenterLos AngelesCaliforniaUnited States
Bradenton Research Center, Inc.BradentonFloridaUnited States
Clinical Neuroscience Solutions, IncOrlandoFloridaUnited States
Atlanta Center for Medical ResearchAtlantaGeorgiaUnited States
Sheppard Pratt Health SystemTowsonMarylandUnited States
Adams Clinical BostonBostonMassachusettsUnited States
Princeton Medical InstitutePrincetonNew JerseyUnited States
University of Cincinnati Psychiatry- Anxiety Disorders Research ProgramCincinnatiOhioUnited States
Neuro-Behavioral Clinical Research, Inc.North CantonOhioUnited States
Austin Clinical Trial PartnersAustinTexasUnited States
Core Clinical ResearchEverettWashingtonUnited States
A-shine s.r.o.PilsenCzechia
Institut Neuropsychiatricke Pece (INEP)PragueCzechia
Psyon s.r.o.PragueCzechia
Cabinet Dr.Desbonnet : Résidence Saint MichelDouaiFrance
Hôpital Conception, CIC Centre, bat néphrologie 3eme étageMarseilleFrance
CMMEParisFrance
GHU Paris Psychiatrie et NeurosciencesParisFrance
Centre Hospitalier du RouvraySotteville-lès-RouenFrance
Department of Psychiatry and Psychotherapy Campus Charité Mitte Charité Universitätsmedizin BerlinBerlinGermany
OVID Clinic BerlinBerlinGermany
Central Institute of Mental HealthMannheimGermany
Klinik für Psychiatrie und Psychotherapie, Abt: Allgemeine Psychiatrie und PsychotherapieTübingenGermany
Centrum Badan Klinicznych PI-House sp. z o.o.GdanskPoland
Department of Psychiatry, UCKGdanskPoland
Department of Affective and Psychotic Disorders, Central Teaching Hospital, Medical University of LodzLodzPoland
Neuroclin GlasgowGlasgowUnited Kingdom
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, St. Nicholas HospitalGosforthUnited Kingdom
4 Medical Clinical SolutionsLondonUnited Kingdom
Clerkenwell Health - Baker StreetLondonUnited Kingdom
Clerkenwell HealthLondonUnited Kingdom
South London and Maudsley NHS Foundation Trust of The Maudsley HospitalLondonUnited Kingdom
4 Medical Clinical SolutionsManchesterUnited Kingdom
St George's Community Health CentreSheffieldUnited Kingdom

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT06809595 on ClinicalTrials.gov →

Last updated in the registry 2026-08-10. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits